Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Minami

Showing results (291-300 of 306) with videos related to

Pageof 31
Sort By:
Science (New York, N.Y.)|November 24, 2007
Emission of coherent THz radiation from superconductorsL Ozyuzer, A E Koshelev, C Kurter, et al.
Optics Express|February 8, 2013
Tunable terahertz emission from the intrinsic Josephson junctions in acute isosceles triangular Bi₂Sr₂CaCu₂O₈+δ mesasK Delfanazari, H Asai, M Tsujimoto, et al.
International Journal of Impotence Research|November 18, 2016
Depressive symptoms and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: the Dogo StudyS Furukawa, T Sakai, T Niiya, et al.
International Journal of Impotence Research|October 28, 2016
Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo StudyS Furukawa, T Sakai, T Niiya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2021
Open-label phase II study of the efficacy of nivolumab for cancer of unknown primaryJ Tanizaki, K Yonemori, K Akiyoshi, et al.
ESMO Open|July 21, 2024
Corrigendum to 'A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody': [ESMO Open volume 9 issue 6 (2024) 103476]T Koyama, N Kiyota, S Boku, et al.
ESMO Open|June 4, 2024
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibodyT Koyama, N Kiyota, S Boku, et al.
Journal of Medicinal Chemistry|February 15, 2001
2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptorH Harada, O Asano, Y Hoshino, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Fundamental and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 2. Clinical evaluation]S Watanabe, H Takahashi, Y Nakamura, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Preclinical and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 1. Susceptibility to bifonazole of clinical isolates of dermatophytes]H Yamaguchi, K Uchida, S Watanabe, et al.
Pageof 31

Showing results (291-300 of 306) with videos related to

Sort By:
Pageof 31
Science (New York, N.Y.)|November 24, 2007
Emission of coherent THz radiation from superconductorsL Ozyuzer, A E Koshelev, C Kurter, et al.
Optics Express|February 8, 2013
Tunable terahertz emission from the intrinsic Josephson junctions in acute isosceles triangular Bi₂Sr₂CaCu₂O₈+δ mesasK Delfanazari, H Asai, M Tsujimoto, et al.
International Journal of Impotence Research|November 18, 2016
Depressive symptoms and prevalence of erectile dysfunction in Japanese patients with type 2 diabetes mellitus: the Dogo StudyS Furukawa, T Sakai, T Niiya, et al.
International Journal of Impotence Research|October 28, 2016
Diabetic peripheral neuropathy and prevalence of erectile dysfunction in Japanese patients aged <65 years with type 2 diabetes mellitus: The Dogo StudyS Furukawa, T Sakai, T Niiya, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 29, 2021
Open-label phase II study of the efficacy of nivolumab for cancer of unknown primaryJ Tanizaki, K Yonemori, K Akiyoshi, et al.
ESMO Open|July 21, 2024
Corrigendum to 'A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibody': [ESMO Open volume 9 issue 6 (2024) 103476]T Koyama, N Kiyota, S Boku, et al.
ESMO Open|June 4, 2024
A phase II trial of paclitaxel plus biweekly cetuximab for patients with recurrent or metastatic head and neck cancer previously treated with both platinum-based chemotherapy and anti-PD-1 antibodyT Koyama, N Kiyota, S Boku, et al.
Journal of Medicinal Chemistry|February 15, 2001
2-Alkynyl-8-aryl-9-methyladenines as novel adenosine receptor antagonists: their synthesis and structure-activity relationships toward hepatic glucose production induced via agonism of the A(2B) receptorH Harada, O Asano, Y Hoshino, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Fundamental and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 2. Clinical evaluation]S Watanabe, H Takahashi, Y Nakamura, et al.
The Japanese Journal of Antibiotics|December 1, 1996
[Preclinical and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 1. Susceptibility to bifonazole of clinical isolates of dermatophytes]H Yamaguchi, K Uchida, S Watanabe, et al.
Pageof 31